IPSEY
Price
$31.62
Change
+$0.48 (+1.54%)
Updated
Aug 13 closing price
Capitalization
10.79B
66 days until earnings call
MILFF
Price
$0.17
Change
-$0.04 (-19.05%)
Updated
Aug 15 closing price
Capitalization
23.11M
Interact to see
Advertisement

IPSEY vs MILFF

Header iconIPSEY vs MILFF Comparison
Open Charts IPSEY vs MILFFBanner chart's image
Ipsen S.A
Price$31.62
Change+$0.48 (+1.54%)
Volume$838
Capitalization10.79B
1CM
Price$0.17
Change-$0.04 (-19.05%)
Volume$125
Capitalization23.11M
IPSEY vs MILFF Comparison Chart in %
Loading...
IPSEY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MILFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSEY vs. MILFF commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSEY is a Buy and MILFF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (IPSEY: $31.62 vs. MILFF: $0.17)
Brand notoriety: IPSEY and MILFF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: IPSEY: 100% vs. MILFF: 17%
Market capitalization -- IPSEY: $10.79B vs. MILFF: $23.11M
IPSEY [@Pharmaceuticals: Generic] is valued at $10.79B. MILFF’s [@Pharmaceuticals: Generic] market capitalization is $23.11M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSEY’s FA Score shows that 2 FA rating(s) are green whileMILFF’s FA Score has 0 green FA rating(s).

  • IPSEY’s FA Score: 2 green, 3 red.
  • MILFF’s FA Score: 0 green, 5 red.
According to our system of comparison, IPSEY is a better buy in the long-term than MILFF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSEY’s TA Score shows that 5 TA indicator(s) are bullish while MILFF’s TA Score has 2 bullish TA indicator(s).

  • IPSEY’s TA Score: 5 bullish, 4 bearish.
  • MILFF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, IPSEY is a better buy in the short-term than MILFF.

Price Growth

IPSEY (@Pharmaceuticals: Generic) experienced а +1.80% price change this week, while MILFF (@Pharmaceuticals: Generic) price change was -17.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Reported Earning Dates

IPSEY is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPSEY($10.8B) has a higher market cap than MILFF($23.1M). IPSEY has higher P/E ratio than MILFF: IPSEY (20.11) vs MILFF (11.52). IPSEY YTD gains are higher at: 10.603 vs. MILFF (-11.567). IPSEY has higher annual earnings (EBITDA): 1.3B vs. MILFF (4.15M). IPSEY has more cash in the bank: 1.45B vs. MILFF (5.86M). MILFF has less debt than IPSEY: MILFF (7.57M) vs IPSEY (869M). IPSEY has higher revenues than MILFF: IPSEY (3.76B) vs MILFF (70.3M).
IPSEYMILFFIPSEY / MILFF
Capitalization10.8B23.1M46,753%
EBITDA1.3B4.15M31,411%
Gain YTD10.603-11.567-92%
P/E Ratio20.1111.52175%
Revenue3.76B70.3M5,349%
Total Cash1.45B5.86M24,684%
Total Debt869M7.57M11,483%
FUNDAMENTALS RATINGS
IPSEY vs MILFF: Fundamental Ratings
IPSEY
MILFF
OUTLOOK RATING
1..100
2787
VALUATION
overvalued / fair valued / undervalued
1..100
28
Undervalued
56
Fair valued
PROFIT vs RISK RATING
1..100
45100
SMR RATING
1..100
9181
PRICE GROWTH RATING
1..100
4847
P/E GROWTH RATING
1..100
1496
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IPSEY's Valuation (28) in the null industry is in the same range as MILFF (56). This means that IPSEY’s stock grew similarly to MILFF’s over the last 12 months.

IPSEY's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for MILFF (100). This means that IPSEY’s stock grew somewhat faster than MILFF’s over the last 12 months.

MILFF's SMR Rating (81) in the null industry is in the same range as IPSEY (91). This means that MILFF’s stock grew similarly to IPSEY’s over the last 12 months.

MILFF's Price Growth Rating (47) in the null industry is in the same range as IPSEY (48). This means that MILFF’s stock grew similarly to IPSEY’s over the last 12 months.

IPSEY's P/E Growth Rating (14) in the null industry is significantly better than the same rating for MILFF (96). This means that IPSEY’s stock grew significantly faster than MILFF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPSEYMILFF
RSI
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
61%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 3 days ago
70%
MACD
ODDS (%)
Bearish Trend 3 days ago
53%
Bullish Trend 3 days ago
67%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
56%
Bearish Trend 3 days ago
67%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
54%
Bullish Trend 3 days ago
68%
Advances
ODDS (%)
Bullish Trend 5 days ago
53%
N/A
Declines
ODDS (%)
Bearish Trend 21 days ago
43%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
74%
Aroon
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
IPSEY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MILFF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SMIN72.650.62
+0.86%
iShares MSCI India Small-Cap ETF
FXE107.960.49
+0.46%
Invesco CurrencyShares® Euro Currency
JJETF6.00N/A
N/A
Barclays Bank PLC
XFLX24.20N/A
N/A
FundX Flexible ETF
VIG209.49-0.58
-0.28%
Vanguard Dividend Appreciation ETF

IPSEY and

Correlation & Price change

A.I.dvisor tells us that IPSEY and LBTSF have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPSEY and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSEY
1D Price
Change %
IPSEY100%
N/A
LBTSF - IPSEY
16%
Poorly correlated
N/A
INIS - IPSEY
7%
Poorly correlated
+3.65%
KHTRF - IPSEY
6%
Poorly correlated
N/A
IPSEF - IPSEY
6%
Poorly correlated
N/A
HYPMY - IPSEY
6%
Poorly correlated
+4.58%
More

MILFF and

Correlation & Price change

A.I.dvisor tells us that MILFF and JUSHF have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MILFF and JUSHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MILFF
1D Price
Change %
MILFF100%
-18.33%
JUSHF - MILFF
5%
Poorly correlated
-10.65%
IPSEY - MILFF
5%
Poorly correlated
N/A
KSPHF - MILFF
3%
Poorly correlated
N/A
MGWFF - MILFF
1%
Poorly correlated
-34.87%
INDV - MILFF
1%
Poorly correlated
+1.25%
More